Arasca enters into a clinical collaboration with Bristol-Myers Squibb to evaluate ERAS-0015 in a clinical study with Navlimetostat.
Arasca enters into a clinical collaboration with Bristol-Myers Squibb to evaluate ERAS-0015 in a clinical study with Navlimetostat.
Want to see every report in real time?
Hundreds of sources worldwide, translated into your language, with alerts for what matters to you.
Sign up free Already have an account? Log in